… GynArt for the trust they have placed in us and are once again looking forward to the successful sale of a CCM-iBIS timelapse incubator. … read more ›
Dear reader, in this latest issue, we’re especially happy to be able to introduce a new member of the Gynemed team: Mr Simon Gaisbauer, who … read more ›
We are looking forward to your visit! … read more ›
Ask for an offer … … read more ›
The monitoring audit according to DIN EN ISO 13485: 2016 of MedCert GmbH took place in our premises from June 2nd to June 3rd 2020. … read more ›
Dear Gynemed, In view of the increasing incidence of Covid-19 infection and its public health consequences, ESHRE regrets to inform you that our Annual Meeting … read more ›
Effective immediately and until further notice, in order to support UPS operations during the COVID-19 outbreak, the commit times for all domestic, transborder and worldwide … read more ›
Dear Customers, Gynemed GmbH & Co KG has decided to suspend all sales force visits in Germany, Austria and Switzerland for the next 2 weeks. … read more ›
Dear Customers, with regard to the corona pandemic, we would like to inform you that we currently are not experiencing any delivery bottlenecks and we … read more ›
Dear customers, the Gynemed office and warehouse will be closed from Tuesday 24th December 2019 until Wednesday 1st January 2020. Our usual service in the … read more ›
Big News: We’re Growing!
Nexpring Health has completed the acquisition of Irvine Scientific’s ART and Cytogenetics
product lines, uniting media, consumables, capital equipment, and lab services under one trusted brand.
✅ Same trusted quality and support
✅ More connected solutions for your entire IVF workflow
✅ No disruption to your current ordering or service
We’re excited to bring even more value to embryologists, clinicians, and fertility clinics, because you’re at the center of everything we do.
Learn More About the Acquisition
You need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Turnstile. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information